A carregar...
The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase‐positive non‐small cell lung cancer
BACKGROUND: Despite recent advances in treating non‐small cell lung cancer (NSCLC) with immune checkpoint inhibitors (ICIs), their role in ALK‐positive NSCLC patients is unclear. We investigated the efficacy of ICIs in patients with ALK‐positive NSCLC. METHODS: Between 2011 and 2018, a total of 14 A...
Na minha lista:
| Publicado no: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons Australia, Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6825904/ https://ncbi.nlm.nih.gov/pubmed/31509890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13195 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|